Figure 1.
Flow chart depicting the screening and selection process for the systematic review of immunosuppression with generic vs. innovator tacrolimus in liver and kidney transplantation on biopsy‐proven acute rejection or bioequivalence.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.